Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Chemoembolization in colorectal liver metastases: the rebirth.

Fiorentini G, Aliberti C, Mulazzani L, Coschiera P, Catalano V, Rossi D, Giordani P, Ricci S.

Anticancer Res. 2014 Feb;34(2):575-84. Review.

PMID:
24510986
2.

Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.

Pernot S, Artru P, Mithieux F, Marsot J, Watkin E, Pellerin O, Lledo G, Chalabreysse P, Desramé J, Taieb J.

Clin Res Hepatol Gastroenterol. 2015 Dec;39(6):e73-7. doi: 10.1016/j.clinre.2015.06.004. Epub 2015 Jul 2.

PMID:
26141343
3.

TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects.

Fiorentini G, Aliberti C, Benea G, Montagnani F, Mambrini A, Ballardini PL, Cantore M.

Hepatogastroenterology. 2008 Nov-Dec;55(88):2077-82.

PMID:
19260480
4.
5.

Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.

Aliberti C, Fiorentini G, Muzzio PC, Pomerri F, Tilli M, Dallara S, Benea G.

Anticancer Res. 2011 Dec;31(12):4581-7.

PMID:
22199334
6.

Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease.

Young S, D'Souza D, Flanagan S, Golzarian J.

Cardiovasc Intervent Radiol. 2017 Apr;40(4):496-501. doi: 10.1007/s00270-016-1537-5. Epub 2016 Dec 21. Review.

PMID:
28004168
7.

Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.

Iezzi R, Marsico VA, Guerra A, Cerchiaro E, Cassano A, Basso M, Devicienti E, Rodolfino E, Barone C, Bonomo L.

Cardiovasc Intervent Radiol. 2015 Dec;38(6):1523-31. doi: 10.1007/s00270-015-1080-9. Epub 2015 Mar 24.

PMID:
25799948
8.

Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations.

Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O'Grady E, Rilling WS, Walker D, Martin RC.

J Vasc Interv Radiol. 2014 Mar;25(3):365-9. doi: 10.1016/j.jvir.2013.11.027.

PMID:
24581461
9.

Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization.

Scevola G, Loreni G, Rastelli M, Sposato S, Ramponi S, Miele V.

Med Oncol. 2017 Mar;34(3):37. doi: 10.1007/s12032-017-0890-9. Epub 2017 Feb 3. Erratum in: Med Oncol. 2017 May;34(5):79.

PMID:
28160267
10.

Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma.

Vogl TJ, Jost A, Nour-Eldin NA, Mack MG, Zangos S, Naguib NN.

Br J Cancer. 2012 Mar 27;106(7):1274-9. doi: 10.1038/bjc.2012.69. Epub 2012 Mar 1.

11.

Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.

Huppert P, Wenzel T, Wietholtz H.

Cardiovasc Intervent Radiol. 2014 Feb;37(1):154-64. doi: 10.1007/s00270-013-0632-0. Epub 2013 May 14.

PMID:
23670568
12.

Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.

Narayanan G, Barbery K, Suthar R, Guerrero G, Arora G.

Anticancer Res. 2013 May;33(5):2077-83.

PMID:
23645758
13.

Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.

Aliberti C, Carandina R, Sarti D, Mulazzani L, Catalano V, Felicioli A, Coschiera P, Fiorentini G.

Anticancer Res. 2016 Jul;36(7):3515-21.

PMID:
27354617
14.

A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof.

Liu DM, Thakor AS, Baerlocher M, Alshammari MT, Lim H, Kos S, Kennedy AS, Wasan H.

Future Oncol. 2015;11(9):1421-8. doi: 10.2217/fon.15.3. Epub 2015 Jan 20. Review.

15.

Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.

Venturini M, Sallemi C, Agostini G, Marra P, Cereda S, Reni M, Aldrighetti L, De Cobelli F, Del Maschio A.

Br J Radiol. 2016 Nov;89(1067):20160247. Epub 2016 Sep 16.

18.

Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.

Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.

Am Surg. 2002 Sep;68(9):827-31.

PMID:
12356160
19.

Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications.

Carling U, Dorenberg EJ, Haugvik SP, Eide NA, Berntzen DT, Edwin B, Dueland S, Røsok B.

Cardiovasc Intervent Radiol. 2015 Dec;38(6):1532-41. doi: 10.1007/s00270-015-1093-4. Epub 2015 Apr 2.

PMID:
25832764
20.

Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors.

Gadaleta CD, Ranieri G.

Crit Rev Oncol Hematol. 2011 Oct;80(1):40-53. doi: 10.1016/j.critrevonc.2010.10.005. Epub 2010 Nov 9. Review.

PMID:
21067940

Supplemental Content

Support Center